The Determinants of Dementia After Stroke (DEDEMAS) Study: Protocol and pilot data

International Journal of Stroke

Volumn 9, Issue 3, 2014, Pages 387-392

  Wollenweber, Frank A ^a   Zietemann, Vera ^a   Rominger, Axel ^a   Opherk, Christian ^a   Bayer Karpinska, Anna ^a   Gschwendtner, Andreas ^a   Coloma Andrews, Lisa ^a   Bürger, Katharina ^a   Duering, Marco ^a   Dichgans, Martin ^a,b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^c Technische Universität München Munich Cluster for Systems Neurology   (Germany)

Author keywords

Poststroke dementia; Poststroke dementia epidemiology; Stroke related outcomes

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; BIOLOGICAL MARKER; DNA; FLUORODEOXYGLUCOSE F 18; RNA;

AGE; AGED; AMBULATORY CARE; ANKLE BRACHIAL INDEX; ARTERIAL WALL THICKNESS; ARTICLE; BIOMETRY; BLOOD; CARDIOEMBOLIC STROKE; CEREBROSPINAL FLUID; CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; CLINICAL PROTOCOL; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DEMENTIA; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; LARGE ARTERY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); MULTIMODAL IMAGING; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; POSITRON EMISSION TOMOGRAPHY; POSTSTROKE DEMENTIA; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; TELEPHONE INTERVIEW; TOAST CLASSIFICATION; WAIST HIP RATIO;

POSTSTROKE DEMENTIA; POSTSTROKE DEMENTIA EPIDEMIOLOGY; STROKE-RELATED OUTCOMES;

AGED; AMYLOID; ANKLE BRACHIAL INDEX; CAROTID INTIMA-MEDIA THICKNESS; COHORT STUDIES; DEMENTIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; POSITRON-EMISSION TOMOGRAPHY; RETINA; STROKE; TREATMENT OUTCOME; WAIST-HIP RATIO;

EID: 84896319661     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/ijs.12092     Document Type: Article

References (34)

1. Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 2009; 8:1006-1018.
2. Pendlebury ST. Stroke-related dementia: rates, risk factors and implications for future research. Maturitas 2009; 64:165-171.
3. Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable alzheimer disease and mild cognitive impairment. Ann Neurol 2009; 66:200-208.
4. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 2010; 120:287-296.
5. Leys D, Henon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol 2005; 4:752-759.
6. Editorial of the Lancet N. A united approach to vascular disease and neurodegeneration. Lancet Neurol 2012; 11:293.
7. Dichgans M, Zietemann V. Prevention of vascular cognitive impairment. Stroke 2012; 43:3137-3146.
8. Jorm AF. A short form of the informant questionnaire on cognitive decline in the elderly (iqcode): development and cross-validation. Psychol Med 1994; 24:145-153.
9. Jorm AF. The informant questionnaire on cognitive decline in the elderly (iqcode): a review. Int Psychogeriatr 2004; 16:275-293.
10. Ringleb PA, Bousser MG, Ford G etal. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25:457-507.
11. McKhann GM, Knopman DS, Chertkow H etal. The diagnosis of dementia due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:263-269.
12. Sachdev PS, Brodaty H, Valenzuela MJ etal. The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology 2004; 62:912-919.
13. Albert MS, DeKosky ST, Dickson D etal. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the national institute on aging-Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 2011; 7:270-279.
14. Berres M, Monsch AU, Bernasconi F, Thalmann B, Stahelin HB. Normal ranges of neuropsychological tests for the diagnosis of Alzheimer's disease. Stud Health Technol Inform 2000; 77:195-199.
15. Bäumler G. Farb-wort-interferenztest (fwit) nach j.R. Stroop. Göttingen, Hogrefe, 1985.
16. Young JC, Sawyer RJ, Roper BL, Baughman BC. Expansion and re-examination of digit span effort indices on the WAIS-IV. Clin Neuropsychol 2012; 26:147-159.
17. Grober E, Buschke H, Crystal H, Bang S, Dresner R. Screening for dementia by memory testing. Neurology 1988; 38:900-903.
18. Somerville J, Tremont G, Stern RA. The boston qualitative scoring system as a measure of executive functioning in rey-osterrieth complex figure performance. J Clin Exp Neuropsychol 2000; 22:613-621.
19. Huber W, Poeck K, Willmes K. The aachen aphasia test. Adv Neurol 1984; 42:291-303.
20. Butler JA. How comparable are tests of apraxia? Clin Rehabil 2002; 16:389-398.
21. Roger PR, Johnson-Greene D. Comparison of assessment measures for post-stroke depression. Clin Neuropsychol 2009; 23:780-793.
22. Shinar D, Gross CR, Price TR etal. Screening for depression in stroke patients: the reliability and validity of the center for epidemiologic studies depression scale. Stroke 1986; 17:241-245.
23. Gandek B, Ware JE, Jr, Aaronson NK etal. Tests of data quality, scaling assumptions, and reliability of the sf-36 in eleven countries: results from the IQOLA project. International quality of life assessment. J Clin Epidemiol 1998; 51:1149-1158.
24. Glaus A, Muller S. [measuring fatigue of cancer patients in the german-speaking region: development of the fatigue assessment questionnaire]. Pflege 2001; 14:161-170.
25. Morris JC. The clinical dementia rating (cdr): current version and scoring rules. Neurology 1993; 43:2412-2414.
26. Matrisch M, Trampisch U, Klaassen-Mielke R etal. [screening for dementia using telephone interviews: an evaluation and reliability study of the telephone interview for cognitive status (tics) in its modified german version.]. Z Gerontol Geriatr 2011; 45:218-223.
27. Frisoni GB, Fox NC, Jack CR, Jr, Scheltens P, Thompson PM. The clinical use of structural MRI in alzheimer disease. Nat Rev Neurol 2010; 6:67-77.
28. Duering M, Zieren N, Herve D etal. Strategic role of frontal white matter tracts in vascular cognitive impairment: a voxel-based lesion-symptom mapping study in cadasil. Brain 2011; 134:2366-2375.
29. Duering M, Righart R, Csanadi E etal. Incident subcortical infarcts induce focal thinning in connected cortical regions. Neurology 2012; 79:2025-2028.
30. Herholz K, Ebmeier K. Clinical amyloid imaging in Alzheimer's disease. Lancet Neurol 2011; 10:667-670.
31. www.m4.de [homepage on the Internet]. The Cluster - m4 - Die Biotech Cluster Development GmbH; 2010 (updated 1 March 2010). Available at http://www.M4.de/en/index.html (accessed 13 August 2012).
32. Pendlebury ST. Dementia in patients hospitalized with stroke: rates, time course, and clinico-pathologic factors. Int J Stroke 2012; 7:570-581.
33. Gorelick PB, Scuteri A, Black SE etal. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42:2672-2713.
34. Pendlebury ST, Cuthbertson FC, Welch SJ, Mehta Z, Rothwell PM. Underestimation of cognitive impairment by mini-mental state examination versus the montreal cognitive assessment in patients with transient ischemic attack and stroke: a population-based study. Stroke 2010; 41:1290-1293.